LigoCyte Pharmaceuticals Inc
Amendment
CIK: 0001400794·Pharmaceuticals·DELAWARE·Filed: Aug 14, 2009
Total Offering
$29,490,335
Amount Sold
$29,490,335
Investors
23
First Sale
Mar 18, 2008
Offering Details
- Type
- Equity, Other: includes two warrants to purchase Series C Preferred Stock
- Exemptions
- Rule 506
- Entity Type
- Corporation
- Year Incorporated
- 2008
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Donald P. Beeman | |
| Larry Mikkola | |
| Rob Goodwin | |
| Ivor Royston, M.D. | |
| Ben Auspitz | |
| J. Donald deBethizy, Ph.D. | |
| C. Boyd Clarke | |
| Markus Goebel, M.D., Ph.D. | |
| Hironori Hozoji | |
| George Kemble, Ph.D. |
Company
SEC Filing
0001400794-09-000004
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free